Chimerix, Inc. to Present at Morgan Stanley and Stifel Healthcare Conferences in September
DURHAM, N.C., Sept. 6, 2013 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today presentations at the following upcoming investor conferences in September:
Help employers find you! Check out all the jobs and post your resume.